United States · FDA National Drug Code directory
ADENOSINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1511_b98519b2-197f-5a71-e053-2995a90ab79a
- Product NDC
- 51662-1511
- Form
- INJECTION
- Composition / generic term
- ADENOSINE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210121
- Source listing expiry
- 20261231
Source-listed ingredients
- ADENOSINE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (51662-1511-1) / 4 mL in 1 SYRINGE · 51662-1511-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →